Literature DB >> 32868218

Left Ventricular Remodeling After Transcatheter Mitral Valve Replacement With Tendyne: New Insights From Computed Tomography.

Miho Fukui1, Paul Sorajja2, Mario Gössl2, Richard Bae2, John R Lesser2, Benjamin Sun3, Alison Duncan4, David Muller5, João L Cavalcante6.   

Abstract

OBJECTIVES: The aim of this study was to describe the anatomic and functional changes in left-sided chambers using computed tomographic angiography (CTA) from baseline to 1 month after transcatheter mitral valve replacement (TMVR) with the Tendyne prosthesis.
BACKGROUND: Data on changes in left atrial and left ventricular (LV) volumes after TMVR implantation are very limited.
METHODS: Patients who underwent TMVR with the Tendyne prosthesis between 2015 and 2018 were analyzed. Changes in LV end-diastolic volume, ejection fraction, LV mass, left atrial volume, and global longitudinal strain were assessed at baseline and 1 month after TMVR using CTA. Specific Tendyne implant characteristics were identified and correlated with remodeling changes.
RESULTS: A total of 36 patients (median age 74 years; interquartile range [IQR]: 69 to 78 years; 78% men; 86% with secondary mitral regurgitation) were included in this study. There were significant decreases in LV end-diastolic volume (281 ml [IQR: 210 to 317 ml] vs. 239 ml [IQR: 195 to 291 ml]; p < 0.001), LV ejection fraction (37% [IQR: 31% to 48%] vs. 30% [IQR: 23% to 40%]; p < 0.001), LV mass (126 g [IQR: 96 to 155 g] vs. 116 g [IQR: 92 to 140 g]; p < 0.001), left atrial volume (171 ml [IQR: 133 to 216 ml] vs. 159 ml [IQR: 125 to 201 ml]; p = 0.027), and global longitudinal strain (-11% [IQR: -17% to -8%] vs. -9% [IQR: -12% to -6%]; p < 0.001) from baseline to 1-month follow-up. Favorable LV end-diastolic volume reverse remodeling occurred in the majority (30 of 36 patients [83%]). Closer proximity of the Tendyne apical pad to the true apex (24 mm [IQR: 21 to 29 mm] vs. 35 mm [IQR: 26 to 40 mm]) was predictive of favorable remodeling (p = 0.037).
CONCLUSIONS: TMVR with Tendyne results in favorable left-sided chamber remodeling in the majority of patients treated, as detected on CTA at 1 month after implantation. CTA identifies favorable post-TMVR changes, which could be related to specific characteristics of the device implantation.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTA; MR; TMVR; computed tomographic angiography; mitral regurgitation; reserve remodeling; transcatheter mitral valve replacement

Mesh:

Year:  2020        PMID: 32868218     DOI: 10.1016/j.jcin.2020.06.009

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  5 in total

1.  Novel 4DCT Method to Measure Regional Left Ventricular Endocardial Shortening Before and After Transcatheter Mitral Valve Implantation.

Authors:  Gabrielle M Colvert; Ashish Manohar; Francisco J Contijoch; James Yang; Jeremy Glynn; Philipp Blanke; Jonathon A Leipsic; Elliot R McVeigh
Journal:  Struct Heart       Date:  2021-07-15

Review 2.  Transcatheter Treatment of Mitral Regurgitation.

Authors:  Angela McInerney; Luis Marroquin-Donday; Gabriela Tirado-Conte; Breda Hennessey; Carolina Espejo; Eduardo Pozo; Alberto de Agustín; Nieves Gonzalo; Pablo Salinas; Iván Núñez-Gil; Antonio Fernández-Ortiz; Hernan Mejía-Rentería; Fernando Macaya; Javier Escaned; Luis Nombela-Franco; Pilar Jiménez-Quevedo
Journal:  J Clin Med       Date:  2022-05-22       Impact factor: 4.964

Review 3.  Current Devices in Mitral Valve Replacement and Their Potential Complications.

Authors:  Livia Gheorghe; Jorn Brouwer; Dee Dee Wang; Nina Wunderlich; Bushra Rana; Benno Rensing; Frank Eefting; Leo Timmers; Martin Swaans
Journal:  Front Cardiovasc Med       Date:  2020-11-27

Review 4.  Current Devices and Complications Related to Transcatheter Mitral Valve Replacement: The Bumpy Road to the Top.

Authors:  Faraj Kargoli; Matteo Pagnesi; Kusha Rahgozar; Ythan Goldberg; Edwin Ho; Mei Chau; Antonio Colombo; Azeem Latib
Journal:  Front Cardiovasc Med       Date:  2021-06-11

Review 5.  Current Status of Catheter-based Mitral Valve Replacement.

Authors:  Elias Rawish; Tobias Schmidt; Ingo Eitel; Christian Frerker
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.